Cargando…
Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice
Sporadic, yet frequent human infections with avian H5N1 influenza A viruses continue to pose a potential pandemic threat. Poor immunogenicity of unadjuvanted H5N1 vaccines warrants developing novel adjuvants and formulations as well as alternate delivery systems to improve their immunogenicity and e...
Autores principales: | Cao, Weiping, Kim, Jin Hyang, Reber, Adrian J., Hoelscher, Mary, Belser, Jessica A., Lu, Xiuhua, Katz, Jacqueline M., Gangappa, Shivaprakash, Plante, Martin, Burt, David S., Sambhara, Suryaprakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115484/ https://www.ncbi.nlm.nih.gov/pubmed/28499553 http://dx.doi.org/10.1016/j.vaccine.2017.05.004 |
Ejemplares similares
-
Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI(®) induces enhanced serological, cellular and protective immune responses
por: Cao, Weiping, et al.
Publicado: (2018) -
A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose
por: Sayedahmed, Ekramy E., et al.
Publicado: (2018) -
Intranasal Protollin Formulated Recombinant SARS-CoV S Protein Elicits Respiratory and Serum Neutralizing Antibodies
por: Barnard, Dale, et al.
Publicado: (2007) -
5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication
por: Ranjan, Priya, et al.
Publicado: (2010) -
Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice
por: Hu, Mary C., et al.
Publicado: (2007)